Ethanol-induced potentiation of rat hepatocyte damage due to 1,2-dibromoethane. 1995

E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
Department of Experimental Medicine and Oncology, University of Torino, Italy.

Low amounts of 1,2-dibromoethane (DBE), not able per se to exert pro-oxidant and cytotoxic activity on rat hepatocyte suspensions, become effective when administered with carbon tetrachloride (CCl4), due to impairment of the glutathione transferase detoxication pathway by CCl4. Treatment of rats with a single dose of ethanol (2.5 g/kg body wt) 2 h before liver cell isolation potentiates the effect of DBE alone on both malonaldehyde formation and lactate dehydrogenase release by the hepatocyte. The potentiation of the DBE effects by ethanol may be through a series of mechanisms, such as a strong inactivation of hepatocyte glutathione transferase similar to that caused by CCl4, an increased basal level of lipid peroxidation and a significant loss of total glutathione.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
December 1986, Biochemical and biophysical research communications,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
June 1987, Toxicology letters,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 2011, Report on carcinogens : carcinogen profiles,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
April 1982, Toxicology and applied pharmacology,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 2004, Report on carcinogens : carcinogen profiles,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 1999, IARC monographs on the evaluation of carcinogenic risks to humans,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 2002, Report on carcinogens : carcinogen profiles,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 1983, Environmental health perspectives,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
January 1990, Teratogenesis, carcinogenesis, and mutagenesis,
E Chiarpotto, and F Biasi, and M Aragno, and A Scavazza, and O Danni, and M U Dianzani, and G Poli
November 1980, Mutation research,
Copied contents to your clipboard!